Doximity’s (DOCS) “Overweight” Rating Reiterated at Piper Sandler

Дата публикации: 10-08-2026 05:36:49

Piper Sandler reissued their overweight rating on shares of Doximity (NYSE:DOCS – Free Report) in a research note released on Friday morning,Benzinga reports. They currently have a $47.00 target price on the stock, up from their previous target price of $42.00. A number of other equities analysts have also recently issued reports on DOCS. BTIG […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Doximity (NYSE:DOCS) Price Target Raised to $31.00	0	12.67	10-08-2026
2	Definium Therapeutics’ (DFTX) “Overweight” Rating Reiterated at Piper Sandler	0	8.75	10-08-2026
3	Somnigroup International’s (SGI) “Overweight” Rating Reiterated at Piper Sandler	0	9.05	10-08-2026
4	Shoulder Innovations’ (SI) Overweight Rating Reiterated at Piper Sandler	0	8.45	10-08-2026
5	Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler	0	9.05	10-08-2026
6	Teleflex’s (TFX) Overweight Rating Reiterated at Piper Sandler	0	10.31	10-08-2026
7	STERIS’s (STE) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
8	Unity Software (NYSE:U) Price Target Raised to $55.00	0	12.66	10-08-2026
9	Piper Sandler Cuts Abacus Global Management (NYSE:ABX) Price Target to $12.00	0	10.81	10-08-2026
10	BP (NYSE:BP) Price Target Raised to $43.00	0	12.22	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.98. Источник: www.americanbankingnews.com.